Lung disease diagnostic tests and biopharma development services
Biodesix runs a clinical diagnostics lab focused on lung disease, pairing LIMS and mass spectrometry (LC-MS, MALDI-TOF) with a heavy data-integration layer: Talend, NiFi, Airbyte, Informatica and SSIS all appear in the stack. Hiring is accelerating and overwhelmingly sales-led, with job posts centered on pushing diagnostic adoption into primary care and pulmonary territories and closing regional coverage gaps.
Notable leadership hires: Sales Director
Biodesix, Inc. is a publicly traded diagnostics company headquartered in Louisville, Colorado, founded in 2006 and employing 201–500 people. It offers diagnostic tests that help clinicians make decisions for patients with lung disease, including lung nodule and cancer assessment. A second business line provides development services to biopharmaceutical, life sciences and research organizations building diagnostic tests, tools and therapeutics. Its laboratory work spans molecular diagnostics, biomarkers and mass spectrometry analysis of biological samples. Hiring is concentrated in the United States.
Biodesix uses LIMS, LC-MS, MALDI-TOF and HPLC in the lab, plus AWS, PostgreSQL, MySQL, Python, Java, Docker, Salesforce, Power BI, Azure DevOps, Talend, Apache NiFi, Airbyte and Informatica.
Yes. Hiring is accelerating and dominated by sales roles, including Sales Director positions, focused on driving diagnostic test adoption in primary care and pulmonary territories across the United States.
Biodesix is headquartered in Louisville, Colorado, United States. It was founded in 2006 and has 201–500 employees.
Other companies in the same industry, closest in size
Biodesix, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.